BOCCUZZI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.410
AS - Asia 3.170
EU - Europa 2.567
SA - Sud America 324
AF - Africa 76
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 8
Totale 11.592
Nazione #
US - Stati Uniti d'America 5.301
SG - Singapore 1.220
CN - Cina 1.069
SE - Svezia 333
FR - Francia 321
VN - Vietnam 309
IT - Italia 295
UA - Ucraina 286
DE - Germania 281
IE - Irlanda 276
BR - Brasile 263
FI - Finlandia 238
KR - Corea 200
GB - Regno Unito 166
PL - Polonia 100
AT - Austria 86
JP - Giappone 76
CA - Canada 70
HK - Hong Kong 60
IN - India 59
DK - Danimarca 46
AU - Australia 37
IQ - Iraq 36
MX - Messico 27
BE - Belgio 26
NL - Olanda 26
AR - Argentina 24
SN - Senegal 24
RU - Federazione Russa 22
BD - Bangladesh 21
ES - Italia 19
ID - Indonesia 17
ZA - Sudafrica 16
UZ - Uzbekistan 14
TR - Turchia 12
CL - Cile 11
GR - Grecia 11
TH - Thailandia 11
TW - Taiwan 10
SA - Arabia Saudita 9
CO - Colombia 7
EU - Europa 7
PK - Pakistan 7
EG - Egitto 6
KE - Kenya 6
MA - Marocco 6
PH - Filippine 6
RO - Romania 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
IR - Iran 5
CR - Costa Rica 4
DZ - Algeria 4
EC - Ecuador 4
HN - Honduras 4
HR - Croazia 4
MY - Malesia 4
TN - Tunisia 4
UY - Uruguay 4
VE - Venezuela 4
BG - Bulgaria 3
CH - Svizzera 3
JO - Giordania 3
MU - Mauritius 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CY - Cipro 2
ET - Etiopia 2
JM - Giamaica 2
KW - Kuwait 2
LT - Lituania 2
LV - Lettonia 2
NG - Nigeria 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
AL - Albania 1
BY - Bielorussia 1
GE - Georgia 1
GL - Groenlandia 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.592
Città #
Beijing 725
Chandler 671
Singapore 639
Ashburn 424
San Jose 290
Santa Clara 290
Dublin 275
Ann Arbor 274
Houston 220
Jacksonville 213
Fairfield 147
Villeurbanne 147
The Dalles 124
Medford 112
Nyköping 102
Princeton 98
Wilmington 98
Dearborn 97
Warsaw 96
Woodbridge 94
Columbus 82
Ho Chi Minh City 80
Torino 80
Lauterbourg 75
Vienna 75
Los Angeles 69
Buffalo 67
Seattle 64
Hanoi 57
Cambridge 54
New York 54
Hong Kong 52
Milan 50
Dong Ket 46
Boardman 43
Boston 41
Seoul 41
Pisa 40
Dallas 38
Munich 32
Tokyo 30
Toronto 28
Hefei 27
Redwood City 27
Fremont 26
Helsinki 26
Brussels 25
Verona 22
Frankfurt am Main 20
Guangzhou 19
Shanghai 19
São Paulo 19
Lachine 18
Sydney 18
Chicago 17
Washington 17
Turku 16
Atlanta 14
London 14
Baghdad 13
Council Bluffs 13
Jakarta 13
Norwalk 13
Da Nang 12
Nanjing 12
Phoenix 12
Zhengzhou 12
Bengaluru 11
Kunming 11
Mexico City 11
Nuremberg 11
Rio de Janeiro 11
San Antonio 11
Detroit 10
Orem 10
Philadelphia 10
Turin 10
Haiphong 9
San Diego 9
Thái Nguyên 9
Amsterdam 8
Montreal 8
Nanchang 8
San Francisco 8
Santiago 8
Stockholm 8
Wuhan 8
Xian 8
Athens 7
Chennai 7
Fuzhou 7
Hải Dương 7
Johannesburg 7
Manchester 7
Porto Alegre 7
Curitiba 6
Dhaka 6
Falkenstein 6
Hangzhou 6
Madrid 6
Totale 7.054
Nome #
AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation 612
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 351
Dysregulation of SREBP2 induces BACE1 expression. 349
Cardiac impairment in rabbits fed a high-fat diet is counteracted by dehydroepiandrosterone supplementation 281
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 245
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 243
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial 221
Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells 199
Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. 197
Epigenetics modifications and therapeutic prospects in human thyroid cancer. 196
Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells 178
Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. 175
Dehydroepiandrosterone inhibits the growth of DMBA-induced rat mammary carcinoma via the androgen receptor. 167
AGEs up-regulates BACE1 through their interaction with RAGE and NFkB activation. 167
Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo. 165
Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line. 159
EFFETTO DELLE ONDE D’URTO SUL DIFFERENZIAMENTO DI CELLULE STAMINALI MESENCHIMALI IN CELLULE OSTEOPROGENITRICI 152
Adrenal androgen action in breast cancer. 150
Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. 150
EFFECTS OF PANOBINOSTAT, A NOVEL DEACETYLASE INHIBITOR, IN PRIMARY CULTURES OF ANAPLASTIC THYROID TUMOURS 148
THE DEACETYLASE INHIBITOR PANOBINOSTAT IS A CYTOTOXIC DRUG AND INDUCER OF IODINE UPTAKE IN ANAPLASTIC THYROID CANCER PRIMARY CULTURES 141
Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients 140
The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS) 135
5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol. 134
THE DEACETYLASE INHIBITOR PANOBINOSTAT INHIBITS THE INVASIVE ACTIVITY OF ANAPLASTIC THYROID CANCER CELLS 134
Oxygen free radical scavenger properties of dehydroepiandrosterone. 133
Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. 133
Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. 132
Histone Deacetylase Inhibition Modulates E-CadherinExpression and Suppresses Migration and Invasion ofAnaplastic Thyroid Cancer Cells 132
Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients 132
Dehydroepiandrosterone in diabetic rats: protection against NFkB activation. 130
ADRENAL ANDROGEN ACTION IN BREAST CANCER 129
Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: an indirect action. 128
Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. 126
LOOKING FOR THE MOLECULAR BRIDGE BETWEEN SEX HORMONE-BINDING GLOBULIN (SHBG) AND BREAST CANCER CELLS 125
Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. 125
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 124
Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib 123
AROMATASE FAILS TO MEDIATE THE PROLIFERATIVE EFFECTS OF ADRENAL ANDROGENS ON CULTURED MCF-7 BREAST CANCER CELLS. 122
Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single istitution in the past five years 122
Valproic acid restores ER-alpha and antiestrogen sensitivity to ER-alpha-negative breast cancer cells 120
Oxidative stress and cardiac fribiosis in diabetics rats 120
Ectopic secretion of LH by an endocrine pancreatic tumor 119
Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure 118
EFFECTS OF THE pan-DAC INHIBITOR LBH589 IN ESTROGEN SENSITIVE AND INSENSITIVE BREAST CANCER CELLS. 116
Dehydroepiandrosterone concentration in breast cancer tissue is related to its plasma gradient across the mammary gland. 115
Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol. 113
Indirect growth inhibition of the MDA-MB-231 hormone-independent breast cancer cell line by dihydrotestosterone. 113
NT2 neurons, a classical model for Alzheimer's disease, are highly susceptible to oxidative stress 112
Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing's disease. 110
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells 108
Oxidative and nitrosative stress in brain mitochondria of diabetic rats 108
Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. 107
Dehydroepiandrosterone prevents the decrease in bovine retinal capillary pericytes number induced in vitro by high glucose 106
High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells 106
THE pan-DAC INHIBITOR LBH589 INDUCES NIS (SODIUM-IODIDE SYMPORTER) EXPRESSION IN BREAST CANCER 106
Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation. 105
Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes 105
Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats 105
Dehydroepiandrosterone and diabetic complications 105
Dehydroepiandrosterone prevents the decrease in bovine retinal capillary pericytes number induced in vitro by high glucose. I 100
Diabetes and muscle wasting: regulatory effect of dehydroepiandrosterone. 99
Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells. 97
Effect of oxidative stress on muscle wasting in diabetic rats. 97
Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta 96
Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells 95
THE pan-DAC INHIBITOR LBH589 INDUCES E-CADHERIN EXPRESSION IN ESTROGEN-RECEPTOR NEGATIVE BREAST CANCER CELLS. 94
Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells 89
Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia 89
Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. 89
Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment 89
Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stress 86
SREBP-1c in NAFDL induced by Western-type high-fat diet plus fructose in rats 85
THE ANTIANDROGEN FLUTAMIDE INHIBITS GROWTH OF MCF-7 HUMAN BREAST CANCER CELL LINE. 84
Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series 84
Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat 81
Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide. 78
Inhibitory effect of hydroxyflutamide plus tamoxifen on oestradiol-induced growth of MCF-7 breast cancer cells. 78
Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer. 77
EFFECT OF CYPROTERONE ACETATE THERAPY ON GONADOTROPIN RESPONSE TO SYNTHETIC LUTEINIZING HORMONE RELEASING HORMONE (LH RH) IN GIRLS WITH IDIOPATHIC PRECOCIOUS PUBERTY. 76
Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells. 72
Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition. 70
Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells 70
Possibile ruolo terapeutico del deidroepiandrosterone nell' insufficienza surrenalica e nell' invecchiamento 70
Oxidative derangement in rat synaptosomes induced by hyperglycaemia: restorative effect of dehydroepiandrosterone treatment. 68
Impulsive and basal ACTH secretion phases in normal subjects, in obese subjects with signs of adrenocortical hyperfunction and in hyperthyroid patients. 67
Prevention of carbon tetrachloride-induced lipid peroxidation in liver microsomes from dehydroepiandrosterone-pretreated rats. 67
Oxidative stress impairs skeletal muscle repair in diabetic rats 67
Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone. 66
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines 66
Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line. 63
Emerging molecular therapies of advanced thyroid cancer. 63
Totale 11.894
Categoria #
all - tutte 37.397
article - articoli 0
book - libri 0
conference - conferenze 5.871
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021113 0 0 0 0 0 0 0 0 0 0 0 113
2021/2022892 47 35 48 43 40 30 57 47 41 44 180 280
2022/20231.509 180 135 66 185 129 356 109 95 147 17 63 27
2023/2024620 79 115 38 28 57 119 18 37 2 8 46 73
2024/20251.572 9 100 33 127 430 74 38 77 245 90 112 237
2025/20262.931 382 146 193 381 390 143 532 81 284 196 144 59
Totale 11.894